Holding(s) in Company

Advanced Medical Solutions Grp PLC 28 February 2008 TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Advanced Medical Solutions 2. Reason for notification (yes/no) An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to notification obligation: AXA S.A, 25 Avenue Matignon, 75008 Paris and its group companies 4. Full name of shareholder(s) (if different from 3): 5. Date of transaction (and date on which the threshold is crossed or reached if different): 26/02/08 6. Date on which issuer notified: 27/02/08 7. Threshold(s) that is/are crossed or reached: 13% 8: Notified Details A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transaction shares the triggering transaction If possible use Number of Number of Number of Number of voting rights Percentage of voting ISIN code shares voting shares rights rights Direct Indirect Direct Indirect Ordinary 5p shares 18,946,661 18,946,661 451,161 415,161 18,697,057 0.29 13.07 GB0004536594 B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of voting instrument period/date that may be acquired rights (if the instrument exercised/converted) Total (A+B) Number of voting rights Percentage of voting rights 19,112,218 13.36 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: Name of the Company/Fund No of shares % of issued share cap Sun Life Pensions Mgmt Ltd 15,161 0.01 Direct Sun Life Pensions Mgmt Ltd 400,000 0.28 Direct AXA Framlington 10,000,000 6.99 Framlington Innovative Growth Indirect AXA Framlington 5,100,000 3.56 Health Indirect Framlington onshore private clients 2,631,500 1.84 Indirect AWF Framlington Health 965,557 0.67 Indirect Total Direct 415,161 0.29 Total Indirect 18,697,057 13.07 Total 19,112,218 13.36 Proxy Voting: 10. Name of proxy holder: N/A 11. Number of voting rights proxy holder will cease N/A to hold: 12. Date on which proxy holder will cease to hold N/A voting rights: 13. Additional information: 14 Contact name: Mary Tavener 15. Contact telephone name: +44 (0) 1606 545509 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings